Equibles does not estimate personal net worth.
Get an email with a short summary when Arcadia Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get RKDA alertsPam Haley is recorded as CFO at Arcadia Biosciences, Inc. (RKDA). Pam Haley has spoken on 8 earnings calls across 1 company, most recently for Arcadia Biosciences, Inc. on November 10, 2022. Arcadia Biosciences, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Arcadia Biosciences, Inc. includes Kevin Comcowich (CEO), Rajendra Ketkar (CEO), Stan Jacot (CEO) and 7 others.
“As Stan noted, we had anticipated reduced revenue in the third quarter as we have turned our focus on our higher-margin brands.”
“As Stan noted, we realized significant growth in our revenues this quarter.”
“As mentioned at the onset of the call, we are pleased with the financial results achieved this quarter. Total revenues recognized for the first quarter of 2022 were $3.2 million compared to $828,000 in the first quarter of 2021.”
“As Stan mentioned at the onset of the call, we have spent considerable time evaluating our business lines, determining which ones to grow and build and which ones to deemphasize.”
“I’d like to take a few moments to share the financial highlights for the recent quarter and year-to-date with you now. As Matt mentioned at the onset of the call, we are pleased with the revenue performance of the brands acquired last quarter of Q2.”
Packaged Foods · Consumer Defensive
CFO
